104 related articles for article (PubMed ID: 9333836)
1. [Quality of life with intensive insulin therapy: a prospective comparison of insulin pen and pump].
Schiffers T
Psychother Psychosom Med Psychol; 1997 Jul; 47(7):249-54. PubMed ID: 9333836
[TBL] [Abstract][Full Text] [Related]
2. Quality of life and treatment satisfaction in adults with Type 1 diabetes: a comparison between continuous subcutaneous insulin infusion and multiple daily injections.
; Nicolucci A; Maione A; Franciosi M; Amoretti R; Busetto E; Capani F; Bruttomesso D; Di Bartolo P; Girelli A; Leonetti F; Morviducci L; Ponzi P; Vitacolonna E
Diabet Med; 2008 Feb; 25(2):213-20. PubMed ID: 18201210
[TBL] [Abstract][Full Text] [Related]
3. Investigation of quality of life and family burden issues during insulin pump therapy in children with Type 1 diabetes mellitus--a large-scale multicentre pilot study.
Müller-Godeffroy E; Treichel S; Wagner VM;
Diabet Med; 2009 May; 26(5):493-501. PubMed ID: 19646189
[TBL] [Abstract][Full Text] [Related]
4. The impact of continuous subcutaneous insulin infusion on health-related quality of life in children and adolescents with type 1 diabetes.
Júlíusson PB; Graue M; Wentzel-Larsen T; Søvik O
Acta Paediatr; 2006 Nov; 95(11):1481-7. PubMed ID: 17062481
[TBL] [Abstract][Full Text] [Related]
5. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
Bode BW
Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
[TBL] [Abstract][Full Text] [Related]
6. Correlates of quality of life in adults with type 1 diabetes treated with continuous subcutaneous insulin injection.
Franciosi M; Maione A; Pomili B; Amoretti R; Busetto E; Capani F; Bruttomesso D; Di Bartolo P; Girelli A; Leonetti F; Morviducci L; Ponzi P; Vitacolonna E; Nicolucci A
Nutr Metab Cardiovasc Dis; 2010 Jan; 20(1):7-14. PubMed ID: 19747804
[TBL] [Abstract][Full Text] [Related]
7. Continuous subcutaneous insulin infusion benefits quality of life in preschool-age children with type 1 diabetes mellitus.
Opipari-Arrigan L; Fredericks EM; Burkhart N; Dale L; Hodge M; Foster C
Pediatr Diabetes; 2007 Dec; 8(6):377-83. PubMed ID: 18036064
[TBL] [Abstract][Full Text] [Related]
8. Pediatric quality of life in transitioning to the insulin pump: does prior regimen make a difference?
Cogen FR; Henderson C; Hansen JA; Streisand R
Clin Pediatr (Phila); 2007 Nov; 46(9):777-9. PubMed ID: 17585009
[TBL] [Abstract][Full Text] [Related]
9. Psychological impact of continuous subcutaneous insulin infusion pump therapy in non-selected newly diagnosed insulin dependent (type 1) diabetic children: evaluation after two years of therapy.
Slijper FM; De Beaufort CE; Bruining GJ; De Visser JJ; Aarsen RS; Kicken DA; Van Strik R
Diabete Metab; 1990; 16(4):273-7. PubMed ID: 2265733
[TBL] [Abstract][Full Text] [Related]
10. [Assessment of metabolic control and safety of continuous subcutaneous insulin infusion in prepubertal children with type 1 diabetes mellitus].
Minkina-Pedras M; Jarosz-Chobot P; Małecka-Tendera E; Deja G
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):171-6. PubMed ID: 16232370
[TBL] [Abstract][Full Text] [Related]
11. Quality of life and diabetes knowledge of young persons with type 1 diabetes: Influence of treatment modalities and demographics.
O'Neil KJ; Jonnalagadda SS; Hopkins BL; Kicklighter JR
J Am Diet Assoc; 2005 Jan; 105(1):85-91. PubMed ID: 15635351
[TBL] [Abstract][Full Text] [Related]
12. Effects of metabolic control, patient education and initiation of insulin therapy on the quality of life of patients with type 2 diabetes mellitus.
Braun A; Sämann A; Kubiak T; Zieschang T; Kloos C; Müller UA; Oster P; Wolf G; Schiel R
Patient Educ Couns; 2008 Oct; 73(1):50-9. PubMed ID: 18583087
[TBL] [Abstract][Full Text] [Related]
13. [Continuous subcutaneous insulin infusion (CSII) in treating young diabetic patients].
Buczkowska EO; Dworzecki T; Wiedermann G; Malanowicz B; Szot D
Przegl Lek; 2005; 62(1):49-53. PubMed ID: 16053222
[TBL] [Abstract][Full Text] [Related]
14. Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues.
Torres I; Ortego J; Valencia I; García-Palacios MV; Aguilar-Diosdado M
Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):378-85. PubMed ID: 19629931
[TBL] [Abstract][Full Text] [Related]
15. Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up.
Sulli N; Shashaj B
Diabet Med; 2006 Aug; 23(8):900-6. PubMed ID: 16911629
[TBL] [Abstract][Full Text] [Related]
16. Why pumps? Continuous subcutaneous insulin infusion for children and adolescents with type 1 diabetes.
Weintrob N; Shalitin S; Phillip M
Isr Med Assoc J; 2004 May; 6(5):271-5. PubMed ID: 15151365
[TBL] [Abstract][Full Text] [Related]
17. In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine.
Bruttomesso D; Crazzolara D; Maran A; Costa S; Dal Pos M; Girelli A; Lepore G; Aragona M; Iori E; Valentini U; Del Prato S; Tiengo A; Buhr A; Trevisan R; Baritussio A
Diabet Med; 2008 Mar; 25(3):326-32. PubMed ID: 18307459
[TBL] [Abstract][Full Text] [Related]
18. Continuous subcutaneous insulin infusion with short-acting insulin analogues or human regular insulin: efficacy, safety, quality of life, and cost-effectiveness.
Radermecker RP; Scheen AJ
Diabetes Metab Res Rev; 2004; 20(3):178-88. PubMed ID: 15133748
[TBL] [Abstract][Full Text] [Related]
19. [Pen-type insulin dispenser for intensive insulin therapy].
Pogátsa G; Koltai MZ
Orv Hetil; 1993 Aug; 134(34):1861-4. PubMed ID: 8355976
[TBL] [Abstract][Full Text] [Related]
20. Effect of patient-selected intensive insulin therapy on quality of life.
Chantelau E; Schiffers T; Schütze J; Hansen B
Patient Educ Couns; 1997 Feb; 30(2):167-73. PubMed ID: 9128618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
